Paraoxonase 1 gene polymorphism does not affect clopidogrel response variability but is associated with clinical outcome after PCI.
Paraoxonase (PON) is a high-density-lipoprotein (HDL) associated enzyme with antioxidative and anti-atherogenic property. Its function is associated with coronary artery disease and its activity genetically controlled. We evaluated whether genetic variation of PON-1 is associated with clinical outco...
Main Authors: | Kyung Woo Park, Jin Joo Park, Jeehoon Kang, Ki-Hyun Jeon, Si-Hyuck Kang, Jung-Kyu Han, Sang Eun Lee, Han-Mo Yang, Hae-Young Lee, Hyun-Jae Kang, Bon-Kwon Koo, Byung-Hee Oh, Young-Bae Park, Hyo-Soo Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3572125?pdf=render |
Similar Items
-
Efficacy and Safety of Long-Term and Short-Term Dual Antiplatelet Therapy: A Meta-Analysis of Comparison between Asians and Non-Asians
by: You-Jeong Ki, et al.
Published: (2020-02-01) -
The Predictors of Target Lesion Revascularization and Rate of In-Stent Restenosis in the Second-Generation Drug-Eluting Stent Era
by: Chengbin Zheng, et al.
Published: (2019-01-01) -
The natural course of nonculprit coronary artery lesions; analysis by serial quantitative coronary angiography
by: Jeehoon Kang, et al.
Published: (2018-06-01) -
Association of Side-Branch Treatment and Patient Factors in Left Anterior Descending Artery True Bifurcation Lesions: Analysis from the GRAND-DES Pooled Registry
by: Gyu Chul Oh, et al.
Published: (2020-01-01) -
Incidence of clopidogrel resistance in 100 patients undergoing PCI
by: M. Vivek, et al.
Published: (2017-11-01)